Adarsh Kumar, Kuber Kumar Bhagat, Ankit Kumar Singh, Harshwardhan Singh, Tanuja Angre, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid Emwas and Pradeep Kumar
RSC Adv., 2023,13, 6872-6908
From themed collection:
2023 Reviews in RSC Advances
Abstract
Pyrido[2,3-d]pyrimidines against various types of cancer.
Vaibhav B. Yadav, Shailee V. Tiwari, S. Hemant Kumar and Santosh R. Deshmukh
RSC Med. Chem., 2026,17, 565-580
Abstract
The study involves the rational design, synthesis, and biological evaluation of novel pyrido[2,3-b][1,4]oxazine derivatives for their anticancer activity, apoptosis induction, EGFR-TK autophosphorylation inhibition, and molecular docking studies.
Fernanda A. Rosa, Davana S. Gonçalves, Karlos E. Pianoski, Michael J. V. da Silva, Franciele Q. Ames, Rafael P. Aguiar, Hélito Volpato, Danielle Lazarin-Bidóia, Celso V. Nakamura and Ciomar A. Bersani-Amado
RSC Med. Chem., 2024,15, 1038-1045
Abstract
The new pyrido[2,3-d]pyridazine-2,8-dione 7c showed potential anti-inflammatory activity as a COX-1/COX-2 dual inhibitor.
Muhammad Rashid, Muhammad Khalid, Abida Ashraf, Tahira Saleem, Iqra Shafiq, Muhammad Azeem Shakil, Briha Zainab, Attalla F. El-kott, Muhammad Yaqub and Zahid Shafiq
RSC Adv., 2023,13, 32160-32174
Abstract
We synthesized novel pyrido[2,3-b]pyrazin based heterocyclic compounds (4–7) and their chemical structures were ascertained by spectral techniques (NMR, FT-IR).
Karina S. Wong, Mohammad Ghanbari and Bruce A. Arndtsen
Chem. Commun., 2025,61, 4192-4195
Abstract
We describe here the development of a new class of palladium catalyzed multicomponent coupling reaction for the assembly of pyrido[2,1-α]isoindoles via the carbonylative coupling of imines, bromopyridines and aryne derivatives.